NGNE vs STRO
Comparison between Neoleukin Therapeutics Inc (NGNE, Company) and Sutro Biopharma Inc (STRO, Company).
Both NGNE and STRO are from the Healthcare sector.
5-Year PerformanceNGNE has outperformed STRO, delivering a return of -31.1% compared to -31.7%
NGNE vs STRO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
NGNE vs STRO - Historical Returns
Returns include dividend reinvestment.
NGNE vs STRO - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | NGNE | STRO |
|---|---|---|
| 2026 | +56.40% | +170.35% |
| 2025 | -10.00% | -40.05% |
| 2024 | +15.05% | -59.74% |
| 2023 | +91.88% | -46.51% |
| 2022 | -90.27% | -47.22% |
| 2021 | -65.89% | -28.22% |
| 2020 | +18.99% | +81.07% |
| 2019 | +428.76% | +9.02% |
| 2018 | -82.00% | -40.66% |
| 2017 | -27.41% | N/A |
| 2016 | +33.90% | N/A |
| 2015 | +63.56% | N/A |
| 2014 | -37.24% | N/A |
NGNE vs STRO Drawdown Comparison
The maximum drawdown for NGNE was -98.34%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The maximum drawdown for STRO was -98.10%, occurring on Apr 17, 2025. This drawdown has not yet recovered.
The current NGNE drawdown is -92.88%. The current STRO drawdown is -89.24%.
| Rank | NGNE | STRO |
|---|---|---|
| #1 | -98.34% Aug 14, 2015 - Apr 8, 2025 | -98.10% Jan 22, 2021 - Apr 17, 2025 |
| #2 | -89.57% Mar 12, 2014 - Aug 10, 2015 | -59.28% Sep 27, 2018 - Nov 6, 2020 |
| #3 | -16.18% Aug 11, 2015 - Aug 14, 2015 | -13.55% Dec 17, 2020 - Jan 7, 2021 |
| #4 | N/A | -12.49% Nov 17, 2020 - Dec 4, 2020 |
| #5 | N/A | -8.27% Nov 9, 2020 - Nov 13, 2020 |
| #6 | N/A | -6.71% Dec 4, 2020 - Dec 16, 2020 |
| #7 | N/A | -3.18% Jan 15, 2021 - Jan 22, 2021 |
| #8 | N/A | -3.15% Jan 8, 2021 - Jan 15, 2021 |
Correlation
Correlation between NGNE and STRO is 0.72 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks